GB1277266A - 07-acetylgonanes and derivatives therefor - Google Patents
07-acetylgonanes and derivatives thereforInfo
- Publication number
- GB1277266A GB1277266A GB326571A GB326571A GB1277266A GB 1277266 A GB1277266 A GB 1277266A GB 326571 A GB326571 A GB 326571A GB 326571 A GB326571 A GB 326571A GB 1277266 A GB1277266 A GB 1277266A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- compounds
- group
- polycarbonalkyl
- ols
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1277266 16α - Alkyl - 13 - polycarbonalkylgonane compounds AMERICAN HOME PRODUCTS CORP 30 July 1969 [30 July 1968] 3265/71 Divided out of 1277264 Headings C2C and C2U 13 - Polycarbonalkyl - 17# - acetyl - 16α- alkyl - gonane compounds and the corresponding 17α-ols and the D-homo-analogues of these compounds, are prepared by alkylating or alkylating and oxidizing the corresponding 13- polycarbonalkyl - 17 - acetyl - gon - 16 - ene compounds and their D-homo analogues. The alkylation may be effected with an alkyl magnesium halide with subsequent acid treatment of the enolate first-formed and the oxidation directly with molecular oxygen or by using the Grignard reagent in the presence of an acyl halide, reacting the resulting enol-acylate with a peracid and hydrolysing the product. In the products, a 17α-OH group may be acylated, a 3-alkoxy-gona-1,3,5(10)-triene may be Birch reduced to a corresponding 2,5(10)-diene and this may be hydrolysed to a gon-4-en-3-one, a 17# - (α - hydroxyethyl) group formed in the Birch reduction may be oxidized to a 17#- acetyl group, and a 20-keto group may be protected as an ethylene-ketal and released again after the Birch reduction. Also described are 3-enol-acylation of #<SP>4</SP> - 3 - ones and hydrolysis of the enol acylates, hydrolysis of #<SP>5</SP>-3- acyloxy compounds to #<SP>5</SP>-3-ols and oxidation of these to #<SP>4</SP>-3-ones, and standard introductions of 6-halo, 6-methyl and 10-methyl substituents and #<SP>1</SP>, #<SP>6</SP> and #<SP>9(10)</SP> double bonds, via intermediates including 5α,6α-epoxides, 6α,7α-epoxides, 6# - methyl - 5α - ols and #<SP>3,5</SP> - 3- acyloxy - 6 - hydroxymethyl and #<SP>4</SP> - 3 - keto- 6-methylene compounds. Novel products have the formulµ wherein R is C 2-6 alkyl; n is 1 or 2; X is a radical containing at least 11 carbon atoms so arranged as to complete a steroid or D-homosteroid nucleus; G is CO or CH(OR<SP>1</SP>) where R<SP>1</SP> is H or C 1-6 alkanoyl; Q is H, OH or OCOR<SP>2</SP> where R<SP>2</SP> is C 1-6 alkyl; and Z is C 1-6 alkyl, provided that when G is CO and Q is H, X is other than where R<SP>7</SP> is H or CH 3 ; and R<SP>5</SP> is C 1-6 alkyl. All the above compounds may be racemates or d-enantiomers. The novel 13-polycarbonalkyl-16α-alkyl steroids have variously estrogenic, anti-estrogenic, anti-lipemic and progestational properties, and they may be made up into pharmaceutical compositions with suitable carriers.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74859468A | 1968-07-30 | 1968-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1277266A true GB1277266A (en) | 1972-06-07 |
Family
ID=25010111
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB326671A Expired GB1277267A (en) | 1968-07-30 | 1969-07-30 | 07-acetylgonanes and derivatives therefor |
GB3816769A Expired GB1277264A (en) | 1968-07-30 | 1969-07-30 | 07-acetylgonanes and derivatives therefor |
GB326571A Expired GB1277266A (en) | 1968-07-30 | 1969-07-30 | 07-acetylgonanes and derivatives therefor |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB326671A Expired GB1277267A (en) | 1968-07-30 | 1969-07-30 | 07-acetylgonanes and derivatives therefor |
GB3816769A Expired GB1277264A (en) | 1968-07-30 | 1969-07-30 | 07-acetylgonanes and derivatives therefor |
Country Status (7)
Country | Link |
---|---|
JP (3) | JPS504657B1 (en) |
BE (1) | BE736832A (en) |
CH (3) | CH594699A5 (en) |
DE (1) | DE1938788A1 (en) |
FR (1) | FR2014015B1 (en) |
GB (3) | GB1277267A (en) |
NL (1) | NL6911623A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015067A2 (en) * | 1989-05-24 | 1990-12-13 | Laboratoire Theramex S.A. | NOVEL METHODS FOR OBTAINING 6-METHYL 19-NOR STEROIDS AND CONVERTING THEM INTO 17α-SUBSTITUTED 19-NOR PREGNADIENES |
FR2700548A1 (en) * | 1993-01-20 | 1994-07-22 | Roussel Uclaf | New process for the preparation of alpha-methylated steroids |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8557950B2 (en) | 2005-06-16 | 2013-10-15 | Grupo Petrotemex, S.A. De C.V. | High intrinsic viscosity melt phase polyester polymers with acceptable acetaldehyde generation rates |
US9267007B2 (en) | 2005-09-16 | 2016-02-23 | Grupo Petrotemex, S.A. De C.V. | Method for addition of additives into a polymer melt |
US7655746B2 (en) | 2005-09-16 | 2010-02-02 | Eastman Chemical Company | Phosphorus containing compounds for reducing acetaldehyde in polyesters polymers |
US7838596B2 (en) | 2005-09-16 | 2010-11-23 | Eastman Chemical Company | Late addition to effect compositional modifications in condensation polymers |
-
1969
- 1969-07-28 JP JP5952969A patent/JPS504657B1/ja active Pending
- 1969-07-30 CH CH554072A patent/CH594699A5/xx not_active IP Right Cessation
- 1969-07-30 CH CH553972A patent/CH585767A5/xx not_active IP Right Cessation
- 1969-07-30 BE BE736832D patent/BE736832A/xx not_active IP Right Cessation
- 1969-07-30 NL NL6911623A patent/NL6911623A/xx unknown
- 1969-07-30 DE DE19691938788 patent/DE1938788A1/en active Pending
- 1969-07-30 GB GB326671A patent/GB1277267A/en not_active Expired
- 1969-07-30 FR FR6926175A patent/FR2014015B1/fr not_active Expired
- 1969-07-30 CH CH1160869A patent/CH564564A5/xx not_active IP Right Cessation
- 1969-07-30 GB GB3816769A patent/GB1277264A/en not_active Expired
- 1969-07-30 GB GB326571A patent/GB1277266A/en not_active Expired
-
1971
- 1971-02-01 JP JP374671A patent/JPS505711B1/ja active Pending
- 1971-02-01 JP JP374571A patent/JPS504659B1/ja active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015067A2 (en) * | 1989-05-24 | 1990-12-13 | Laboratoire Theramex S.A. | NOVEL METHODS FOR OBTAINING 6-METHYL 19-NOR STEROIDS AND CONVERTING THEM INTO 17α-SUBSTITUTED 19-NOR PREGNADIENES |
WO1990015067A3 (en) * | 1989-05-24 | 1991-01-24 | Theramex | NOVEL METHODS FOR OBTAINING 6-METHYL 19-NOR STEROIDS AND CONVERTING THEM INTO 17α-SUBSTITUTED 19-NOR PREGNADIENES |
GR900100394A (en) * | 1989-05-24 | 1991-10-10 | Theramex | New methods for obtaining 6-methyl 19-nor steroides and their conversion in 19-nor pregnadienes 17-a substituted |
FR2700548A1 (en) * | 1993-01-20 | 1994-07-22 | Roussel Uclaf | New process for the preparation of alpha-methylated steroids |
EP0608178A1 (en) * | 1993-01-20 | 1994-07-27 | Roussel Uclaf | New 16-alpha steroid-methylation process |
US5508452A (en) * | 1993-01-20 | 1996-04-16 | Roussel Uclaf | Preparation of 16α-methyl steroids |
Also Published As
Publication number | Publication date |
---|---|
FR2014015B1 (en) | 1976-09-17 |
NL6911623A (en) | 1970-02-03 |
JPS505711B1 (en) | 1975-03-06 |
BE736832A (en) | 1970-01-30 |
JPS504657B1 (en) | 1975-02-22 |
CH564564A5 (en) | 1975-07-31 |
CH585767A5 (en) | 1977-03-15 |
GB1277264A (en) | 1972-06-07 |
GB1277267A (en) | 1972-06-07 |
DE1938788A1 (en) | 1970-02-12 |
CH594699A5 (en) | 1978-01-31 |
FR2014015A1 (en) | 1970-04-10 |
JPS504659B1 (en) | 1975-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1494097A (en) | D-homo-20-keto-pregnanes | |
GB1277266A (en) | 07-acetylgonanes and derivatives therefor | |
GB901293A (en) | Improvements in or relating to steroids | |
GB1146992A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
GB1506833A (en) | 16-substituted steroids of the pregnane series and the preparation of such steroids | |
GB1530615A (en) | 15,16-methylene-steroids of the pregnane series | |
GB1308849A (en) | Process for the preparation of 6alpha-methyl-19-nor-pregnenes | |
GB1206873A (en) | 7alpha-METHYL-ANDROSTENE COMPOUNDS | |
GB1514621A (en) | 13-ethynyl-and 13-(2-halovinyl)-steroids and their preparation | |
GB1383334A (en) | 15alpha,16alpha-methylene-steroids | |
GB1214507A (en) | 03-alkyl-11-oxygenated-gonenes | |
GB978540A (en) | Improvements in or relating to the production of 16ª-alkylthio-17-oxo-steroids | |
US3156711A (en) | Novel delta1-3-desoxyandrostene and delta1, 3-3-desoxyandrostadiene derivatives | |
GB1073988A (en) | Process for preparing steroid compounds, and the compounds thus prepared | |
GB1277265A (en) | 6-substituted-13-polycarbonalkyl-18,19-dinorpregn-4-en-3-ones | |
GB1504132A (en) | 6beta-fluorosteroids of the pregnane series | |
GB980245A (en) | New-6-alkyl-steroids | |
GB1205101A (en) | 3-oxo-a-nor-b-homo-pregnadienes and a process for their manufacture | |
GB711258A (en) | Manufacture of oxidation products of steroids having a semi-cyclic double bond | |
GB1311725A (en) | 18-cyano pregnane compounds and process for their manufacture | |
GB1128044A (en) | 13-(c) alkyl-11-oxygenated gonenes | |
GB1527249A (en) | 6-fluoro-16-methyl-pregna-1,4,8-triene-3,20-diones | |
GB1097656A (en) | A process for the manufacture of steroids of the pregnane series | |
GB1197761A (en) | Processes for the preparation of Steroid Compounds related to Equilenin | |
GB1152128A (en) | Process and Intermediates for the Manufacture of 19-Hydroxycholestanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
429A | Application made for amendment of specification (sect. 29/1949) | ||
429H | Application (made) for amendment of specification now open to opposition (sect. 29/1949) | ||
429D | Case decided by the comptroller ** specification amended (sect. 29/1949) | ||
SPA | Amended specification published | ||
PE20 | Patent expired after termination of 20 years |